Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if amphotericin B is effective against visceral
leishmaniasis in Brazilian children. Amphotericin B will be compared to meglumine antimoniate
which is the current approved drug used for this disease in Brazil.
Phase:
Phase 4
Details
Lead Sponsor:
University of Brasilia
Collaborator:
Ministry of Health, Brazil
Treatments:
Amphotericin B Amphotericin B, deoxycholate drug combination Deoxycholic Acid Liposomal amphotericin B Meglumine Antimoniate